What do you think about this, guys?
Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States
>At the country-level, there appears to be no discernable relationship between percentage of population fully vaccinated and new COVID-19 cases in the last 7 days
>Across the US counties too, the median new COVID-19 cases per 100,000 people in the last 7 days is largely similar across the categories of percent population fully vaccinated
>The sole reliance on vaccination as a primary strategy to mitigate COVID-19 and its adverse consequences needs to be re-examined, especially considering the Delta (B.1.617.2) variant
>For instance, in a report released from the Ministry of Health in Israel, the effectiveness of 2 doses of the BNT162b2 (Pfizer-BioNTech) vaccine against preventing COVID-19 infection was reported to be 39% [6], substantially lower than the trial efficacy of 96%
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481107/?utm_source=draugiem.lv&utm_medium=say&utm_campaign=post_1915469170&fbclid=IwAR1tK4ODG4tP75rQpYG-0Y4xK8kb8ZdpvWUJDO5Ad9R3LbXXVhBQPjuDfF8
How true is this info?
What should we do?
Increases in COVID-19 are unrelated to levels of vaccination across 68 countries and 2947 counties in the United States
>At the country-level, there appears to be no discernable relationship between percentage of population fully vaccinated and new COVID-19 cases in the last 7 days
>Across the US counties too, the median new COVID-19 cases per 100,000 people in the last 7 days is largely similar across the categories of percent population fully vaccinated
>The sole reliance on vaccination as a primary strategy to mitigate COVID-19 and its adverse consequences needs to be re-examined, especially considering the Delta (B.1.617.2) variant
>For instance, in a report released from the Ministry of Health in Israel, the effectiveness of 2 doses of the BNT162b2 (Pfizer-BioNTech) vaccine against preventing COVID-19 infection was reported to be 39% [6], substantially lower than the trial efficacy of 96%
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481107/?utm_source=draugiem.lv&utm_medium=say&utm_campaign=post_1915469170&fbclid=IwAR1tK4ODG4tP75rQpYG-0Y4xK8kb8ZdpvWUJDO5Ad9R3LbXXVhBQPjuDfF8
How true is this info?
What should we do?
